Please login to the form below
9
Revenue 2017Gilead Sciences
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Gilead Sciences' 2013 sales performance.
Gilead Sciences set to acquire MiroBio in deal worth over $400m
Gilead Sciences has announced its plans to acquire UK-based biotechnology company MiroBio. ... The acquisition will allow Gilead to utilise MiroBio’s proprietary discovery platform and entire portfolio of immune inhibitory receptor agonists.
Gilead announces positive Biktarvy data for HIV and hepatitis B
The results were presented at the 24th International AIDS Conference. Gilead Sciences has announced results supporting Biktarvy as a highly effective treatment for people with HIV, including those with HIV and ... Jared Baeten, vice president, HIV
Gilead’s COVID-19 drug Veklury recommends for approval by CHMP
Gilead Sciences (Gilead) has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Commission (EC) has adopted a positive opinion of Veklury (remdesivir), recommending the COVID-19 ... Commenting on the positive opinion,
Gilead invests $85m in Gilead Foundation towards health equity progress
Gilead Sciences has made an investment contribution of $85m to the Gilead Foundation, furthering its aims to build a healthier world for everyone. ... The Gilead Foundation also encourages a culture of employee giving through its donation matching
Gilead - Hep C, Ki?
by 90TEN for Gilead UK &Ireland. Five times more British South Asian people have hepatitis C (HCV) than the wider UK population, and there is a significant barrier to this community ... Gilead Sciences collaborated with NHS England and the Hepatitis C
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
Featured jobs
- AI: powering healthcare, empowering patients Physician perceptions of AI and the future of pharma
- Amgen announces positive results for Solaris biosimilar for paroxysmal nocturnal haemoglobinuria
- Novartis to separate generic drugs division Sandoz to create standalone company
- Sanofi and Sobi’s efanesoctocog alfa granted FDA priority review for haemophilia A
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- Gilead Sciences announce positive results for Trodelvy in breast cancer patients
- Live Webinar: Streamlining Cardiac Care with Real Time Monitors
- FREE Live Webinar - Overcoming Patient Recruitment Challenges in Rare Disease Trials
- Novavax’s COVID-19 vaccine candidate approved by MHRA for adolescents aged 12 to 17
- Novartis' Scemblix receives EC approval for chronic myeloid leukaemia
- AztraZeneca’s Farxiga data shows ‘significant’ mortality benefits in heart failure patients
- BHF announces drug combination could delay need for high-risk surgery in patients with Marfan syndrome
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- Sanofi and Sobi’s efanesoctocog alfa granted FDA priority review for haemophilia A
- COVID-19 linked to higher risk of brain fog, dementia and psychosis in new study
- Medscape: At the Heart of Education at #ESCCongress
- Assessing the value of interim analyses in clinical trials
- Environment: where does the pharmaceutical industry stand?
PMHub
Porterhouse Medical Group
The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...
Latest intelligence
- FREE Live Webinar - Overcoming Patient Recruitment Challenges in Rare Disease Trials
- Innovative Trials and Pfizer invite you to attend the live webinar...
- Beat inflation with virtual meetings and programs
- ...
- AI: powering healthcare, empowering patients Physician perceptions of AI and the future of pharma
- ...
